What if a Research Finding Might Affect a Participant’s Health or Safety?

What Changes When an Unexpected Finding May Put the Participant at Risk?

Many incidental findings can be evaluated deliberately. Researchers may have time to confirm a result, consult an expert, review the participant’s preferences, and decide whether disclosure is appropriate.

But what if the finding suggests something more immediate? A physiological measurement appears dangerously abnormal. A research scan reveals an unexpected abnormality that could require prompt medical assessment. A study procedure uncovers information suggesting that delaying follow-up might expose the participant to serious harm.

At that point, the issue is no longer only whether an individual research result should eventually be returned. Participant welfare and the urgency of the possible risk become central to what the research team should do next.

Potential Health or Safety Risks Require Proportionate Assessment and Escalation

Health and Safety Findings Can Change the Pace of the Ethical Response

Not every abnormal result is a safety emergency

Research produces unusual measurements for many reasons. Equipment can malfunction. Biological measurements fluctuate. Imaging procedures can produce artifacts. Exploratory analyses can generate false positives.

The fact that a result looks alarming does not establish that a participant is in danger. Researchers should therefore distinguish an abnormal observation from a credible health or safety concern.

At the same time, uncertainty should not become an excuse for delay when a plausible serious risk is time-sensitive. The task is to determine what the evidence justifies and how quickly that assessment needs to happen.

Three questions become especially important: credibility, severity, and urgency

These dimensions interact. A highly credible but minor abnormality may not require rapid escalation. A potentially catastrophic interpretation supported by extremely weak evidence may call for urgent expert review rather than immediate disclosure as fact. A credible finding suggesting imminent serious harm may require a much faster response.

Material findings are different from merely interesting findings

Canada’s TCPS 2 provides a useful concept: a material incidental finding is an incidental finding reasonably determined to have significant welfare implications for the participant. Its guidance considers analytic validity, potential significance, and actionability when assessing materiality.

TCPS 2 requires disclosure of material incidental findings within the limits of participant consent and directs researchers who lack the necessary expertise to seek relevant expertise. It also recognizes that when participant welfare may be negatively affected and time is critical to mitigating risk, required protective action may sometimes precede reporting to the research ethics board.

This is one policy framework rather than a universal rule for every jurisdiction, but it illustrates an important ethical distinction: as a finding moves from scientifically interesting to materially relevant to participant welfare, the responsibilities attached to it can change.

The first action may be escalation rather than disclosure

Researchers sometimes assume that protecting the participant means immediately telling them everything that has appeared in the data. That can be premature.

If a researcher lacks the expertise to determine whether an imaging abnormality is clinically significant, rapid specialist review may be the correct first response. If a laboratory result could reflect a measurement problem, appropriate confirmation may be needed. If the result appears immediately dangerous, the study’s clinical or emergency pathway may need to be activated.

Research is not automatically clinical care

Researchers should not imply that participation provides comprehensive medical monitoring unless the study actually provides that service. Research procedures may not meet clinical diagnostic standards, and investigators may not be licensed or qualified to interpret unrelated medical findings.

Still, the research-care distinction does not mean participant welfare becomes irrelevant when an unrelated health problem comes to light. CIOMS states that when enrolled participants are found to have diseases unrelated to the research, researchers should advise them to obtain medical care or refer them for care. It describes such assistance within the broader concept of ancillary care.

The practical responsibility may therefore be referral rather than treatment. Discovering a possible condition does not necessarily make the research team responsible for managing that condition indefinitely.

Urgency can justify a different sequence from ordinary incidental findings

Ordinarily, researchers may have time to move through confirmation, consultation, consent, and carefully planned disclosure. A credible threat requiring rapid intervention may compress that sequence.

For example, TCPS guidance recognizes that when participant welfare may be negatively affected and time is of the essence, researchers may implement required actions before reporting the matter to the research ethics board. That does not mean ethics oversight disappears. It means participant protection need not be delayed solely to preserve the usual administrative order when delay itself could cause harm.

Consent remains relevant, but difficult exceptions can arise

Participant preferences about receiving incidental findings ordinarily matter. TCPS 2, for example, conditions disclosure of material incidental findings on participant consent. Yet it also recognizes a difficult exceptional situation: researchers may have previously undertaken not to disclose findings and later discover an unforeseeable material finding for which a potentially significantly beneficial intervention exists. Its guidance directs researchers in such circumstances to consult the research ethics board about whether an ethical basis exists for disclosure.

The point is not that researchers may casually override a participant’s wishes whenever they believe information is important. Rather, exceptionally consequential findings can create conflicts among autonomy, welfare, prior consent, and professional obligations that require appropriate ethics review.

The participant’s choice about receiving incidental findings should therefore be anticipated as carefully as possible before such a conflict occurs.

Safety findings can also intersect with confidentiality

Some situations involve more than returning information to the participant. Applicable law or professional duties may require information to be communicated to another person or authority. Examples can include certain communicable diseases, child protection obligations, or other legally reportable circumstances, depending on jurisdiction.

Researchers should not assume that confidentiality is either absolute or automatically overridden whenever they perceive danger. The relevant rules can vary substantially by jurisdiction and professional role. The broader question of when confidentiality gives way to a duty to act or report therefore needs separate analysis.

Different kinds of safety threats require different protocols

A medical abnormality found on an MRI is not managed through exactly the same pathway as a disclosure of abuse, suicidal intent, or a credible threat toward another person. All may involve participant or third-party welfare, but the relevant expertise, urgency assessment, reporting obligations, and confidentiality rules differ.

Researchers should use the specific procedures developed for the type of risk involved rather than relying on one generic “safety concern” response.

A Research Measurement Suggests a Potentially Serious Health Problem

The research team has taken the possible risk seriously without converting a research observation into a clinical diagnosis. Both parts matter.

Common Mistakes When Health or Safety May Be at Stake

Match the Speed and Strength of Your Response to the Risk

If your research could reveal health or safety concerns, establish escalation procedures before data collection. Researchers should know whom to contact, what constitutes an urgent concern, what expertise is available, how participants will be referred, and what happens outside ordinary working hours when the study could plausibly generate time-sensitive risks.

The crucial distinction is between responding to a possible danger and claiming certainty about its cause. Researchers can take proportionate protective action while remaining precise about what the research evidence does and does not establish.

When a Finding May Affect Health or Safety

Questions About Findings That May Affect Participant Safety

Possible Danger Changes the Urgency, Not the Standard of Evidence

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.